Revenues for the fourth quarter rose to ₹ 1,722 crore
Torrent Pharmaceuticals posted 11 per cent increase in consolidated net profit at ₹ 228 crore for the fourth quarter ended March 2018, driven by robust sales in domestic market.
The company had reported a net profit of ₹ 206 crore during the same period last year. Revenues for the fourth quarter rose to ₹ 1,722 crore, as compared with ₹ 1,434 crore in the January March period of 2016-17, Torrent Pharmaceuticals said in a regulatory filing. For the year ended March 31, 2018, the company posted a net profit of ₹ 678 crore, down 27 per cent from ₹ 934 crore in 2016-17.Revenues during the year, however, rose by 2 per cent to Rs 6,002 crore, compared with ₹ 5,857 crore in 2016-17.
During the year ended March 31, 2018, the company said its revenues in the domestic market grew by 19 per cent to ₹ 2,351 crore, as against ₹ 1,976 crore in 2016-17. In the US market, the company said its revenues declined to 1,100 crore in 2017-18 as compared with ₹ 1,346 crore in 2016-17. The company’s board recommended a final dividend of ₹ 5 per equity share of face value of ₹ 5 each.
Comments are closed.